

Learn about common and serious Kesimpta side effects, who's most at risk, how to manage them, and when to contact your doctor right away.
Every medication comes with potential side effects, and Kesimpta (Ofatumumab) is no exception. As a biologic that works by depleting certain immune cells, Kesimpta has a specific side effect profile that's important to understand before — and during — treatment.
This guide breaks down the common and serious side effects reported in clinical trials and real-world use, who may be more at risk, and when you should pick up the phone and call your doctor.
Kesimpta is a fully human anti-CD20 monoclonal antibody approved for relapsing forms of multiple sclerosis (MS) in adults. It works by targeting and depleting B cells — a type of white blood cell involved in the immune attacks that damage nerve tissue in MS. It's self-administered as a subcutaneous injection once monthly (after initial loading doses). For a deeper dive, read our complete guide to Kesimpta.
These are the side effects reported most frequently in clinical trials. Most are mild to moderate and tend to improve over time:
These are less common but require immediate medical attention:
Because Kesimpta suppresses part of your immune system, it increases your risk of serious infections. This includes bacterial, viral, and fungal infections that your body might normally fight off. Signs to watch for:
If you've ever had hepatitis B — even if you recovered — Kesimpta can cause the virus to reactivate. This can lead to serious liver damage and even liver failure. Your doctor should screen you for HBV before starting treatment. If you have a history of HBV, you'll need close monitoring.
PML is a rare but potentially fatal brain infection caused by the JC virus. While PML has not been reported in Kesimpta clinical trials for MS, it has occurred with other anti-CD20 therapies and is listed as a warning. Symptoms include:
Contact your doctor immediately if you notice any of these symptoms.
In rare cases, injection-related reactions can be severe, including difficulty breathing, throat swelling, or a drop in blood pressure. This is why your first injection should be supervised by a healthcare professional.
Over time, Kesimpta can reduce your body's levels of immunoglobulins (antibodies), particularly IgM and sometimes IgG. Low immunoglobulins can increase your vulnerability to infections. Your doctor will check these levels periodically.
Kesimpta has not been adequately studied in pregnant women. Because it depletes B cells, there's a theoretical risk to the developing immune system of a fetus. Novartis recommends that women of childbearing potential use effective contraception during treatment and for 6 months after the last dose. It's unknown whether Ofatumumab passes into breast milk.
Clinical trial data in patients over 65 is limited. Older adults may have a higher baseline risk of infection, so the immunosuppressive effects of Kesimpta warrant extra caution.
As noted above, HBV screening is mandatory before starting Kesimpta. Patients with active HBV infection should not take Kesimpta.
Many common side effects can be managed at home with straightforward strategies:
Call your doctor or seek emergency care if you experience:
When in doubt, call. Your neurology team would rather hear from you than have you wait it out.
Kesimpta is a powerful and effective treatment for relapsing MS, and most patients tolerate it well. But understanding the potential side effects — and knowing when to act — helps you stay safe while getting the benefits of treatment.
If cost or access is a concern alongside side effect management, explore our guides on saving money on Kesimpta and finding Kesimpta in stock. And if you're ready to locate a pharmacy, Medfinder can help.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.